Wheeler P R, Besra G S, Minnikin D E, Ratledge C
Department of Applied Biology, University of Hull, UK.
Biochim Biophys Acta. 1993 Apr 7;1167(2):182-8. doi: 10.1016/0005-2760(93)90160-b.
Mycolic acids are high molecular weight hydroxy fatty acids which are a covalently linked part of the cell wall structure of all mycobacteria and their biosynthetic pathways offer potential drug targets. Three good candidates, cis-tetracos-5-enoic acid and R or S trans-6-methyl-tetracos-4-enoic acids, for the key initial intermediates where mycolic acid biosynthesis might diverge from other metabolic pathways, were tested as possible substrates. A cell-wall preparation from Mycobacterium smegmatis, capable of mycolic acid synthesis, was developed to investigate the possible incorporation of these, and other 16 to 24 carbon acids into mycolic acids. The wall preparations were extracted with hexane and suspended in hexane/water (7:1, v/v), and in this low-water assay, only one of these acids, cis-tetracos-5-enoic acid, stimulated the incorporation of radioactive label from [1-14C]acetate into alpha- and alpha'-mycolic acids. The extraction method used did, however, abolish some enzyme activity and mycolic acid biosynthesis was not completely restored by cis-tetracos-5-enoate. The two methyl-branched acids did not enhance the amount of label in epoxymycolic acids. An initial key intermediate in the synthesis of alpha- and alpha'-mycolic acids has therefore been positively identified for the first time; intermediates in the initial stages of the biosynthesis of oxygenated mycolic acids such as epoxymycolates remain to be defined.
分枝菌酸是高分子量的羟基脂肪酸,是所有分枝杆菌细胞壁结构的共价连接部分,其生物合成途径提供了潜在的药物靶点。作为可能的底物,测试了三种良好的候选物,即顺式二十四碳-5-烯酸以及R或S反式-6-甲基-二十四碳-4-烯酸,它们是分枝菌酸生物合成可能与其他代谢途径不同的关键初始中间体。开发了一种来自耻垢分枝杆菌的能够合成分枝菌酸的细胞壁制剂,以研究这些以及其他16至24个碳原子的酸是否可能掺入分枝菌酸中。用己烷提取细胞壁制剂并悬浮于己烷/水(7:1,v/v)中,在这种低水含量测定中,这些酸中只有顺式二十四碳-5-烯酸刺激了[1-14C]乙酸盐的放射性标记掺入α-和α'-分枝菌酸中。然而,所使用的提取方法确实消除了一些酶活性,并且顺式二十四碳-5-烯酸酯并未完全恢复分枝菌酸的生物合成。这两种甲基支链酸并未增加环氧分枝菌酸中的标记量。因此,首次明确鉴定出α-和α'-分枝菌酸合成中的一个初始关键中间体;含氧分枝菌酸如环氧分枝菌酸生物合成初始阶段的中间体仍有待确定。